trastuzumab,tucatinib
seagen
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'tucatinib']
tucatinib/trastuzumab in 2nd line metastatic her2 + biliary tract cancer very positive in small phase 2 study #asco23 
GI medical oncologist, Associate Prof Univ of WI, public health, proud Midwesterner, opinions mine  FCOI: https://t.co/vHScVEaG0b